Which regimen is recommended for prosthetic valve endocarditis?

Which regimen is recommended for prosthetic valve endocarditis?

• A. Rifampin + Gentamicin + Vancomycin
• B. Nafcillin + Gentamicin + Vancomycin
• C. Ceftriaxone + Gentamicin
• D. Daptomycin

Answer: (A)

Prosthetic valve endocarditis requires antibiotics that both cover the common hardware-associated bugs and penetrate the biofilm that forms on artificial valves. Vancomycin provides broad coverage against MRSA and other resistant staphylococci, which are frequent culprits in prosthetic infections. Rifampin is critical here because of its ability to penetrates biofilms and eradicate bacteria tightly adherent to prosthetic surfaces; however, it must never be used alone due to rapid resistance, so it is paired with other agents. Gentamicin adds a rapid, synergistic bactericidal effect with the other drugs, helping achieve quicker bacterial kill. Together, these three drugs address the likely pathogens and the biofilm-associated nature of the infection, making this combination the most effective initial regimen for prosthetic valve endocarditis. Regimens lacking rifampin or relying on a single agent do not adequately tackle biofilm-related persistence, and thus are less appropriate for this condition.

Prosthetic valve endocarditis requires antibiotics that both cover the common hardware-associated bugs and penetrate the biofilm that forms on artificial valves. Vancomycin provides broad coverage against MRSA and other resistant staphylococci, which are frequent culprits in prosthetic infections. Rifampin is critical here because of its ability to penetrates biofilms and eradicate bacteria tightly adherent to prosthetic surfaces; however, it must never be used alone due to rapid resistance, so it is paired with other agents. Gentamicin adds a rapid, synergistic bactericidal effect with the other drugs, helping achieve quicker bacterial kill. Together, these three drugs address the likely pathogens and the biofilm-associated nature of the infection, making this combination the most effective initial regimen for prosthetic valve endocarditis. Regimens lacking rifampin or relying on a single agent do not adequately tackle biofilm-related persistence, and thus are less appropriate for this condition.